Industry Explorers Blaze On

  1. Key Takeaways From The FDA Guidance On DCTs 10/2/2023

    The FDA brought out “The Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency” in a bid to continue clinical trials during the COVID-19 pandemic. There were several measures that were included like the use of EHRs and the use of digital health devices. In May, this year, they provided guidelines for conducting DCTs. In this article we will explore some of the highlights of the FDA guidance for DCTs.

  2. From Robotics To AI … Yesterday's Unknown Is Tomorrow's Promise 10/2/2023

    As part of my professional consulting and patient advocacy work in healthcare, I have learned about AI and seen first-hand the difference it is already making for countless patients and physicians around the world.

  3. Insights On Today's Biotech Market Conditions 10/2/2023

    At Locust Walk, we regularly compile key statistics to illustrate trends in the private and public markets, overall activity levels, and what deals M&A and strategic partnering participants are pursuing. This analysis offers the opportunity for data-driven insights on the current market conditions, how they compare to historic levels, and what they mean for the future.

  4. Insurance Strategies For Sustainable Growth And Risk Management 10/2/2023

    Now is the time for company leaders at all stages to evaluate insurance costs, which can be among the top five most significant budget line items.

  5. Given Drug Development Time Horizons, How Does A Company Best Navigate The Inevitable Vagaries Of Investor Therapeutic/Modality Sentiment And Its Collateral Consequences On Funding? 10/2/2023

    See the answer from Allan Shaw, an independent consultant and chief financial officer at Portage Biotech.

  6. Unlocking The Power Of Empathy In Employee And Customer Experiences 10/2/2023

    By fostering empathy within the workplace, organizations can create a remarkable employee experience that drives employee engagement, customer satisfaction, and, ultimately, business success.

  7. Establishing A Research Function In Biopharma 10/2/2023

    When it was time to double-down on development efforts to feed its pipeline of biologics, Horizon Therapeutics turned to Big Biopharma veteran Robert Stoffel, Ph.D. to lead the effort. Stoffel joined us for an episode of the Business of Biotech podcast to share how he did it.

  8. Using AI To Find And Develop Safer Medicines 10/2/2023

    Montai Health CEO Margo Georgiadis is using what she’s learned at McKinsey, Discover, Google, Mattel, and Ancestry to reinvent drug discovery and development, with a focus on long-term safety.

  9. How Can Leaders Balance Requests Of Employees To Continue Remote Working With The Need For Increased Business Efficiency And Achieving Strong Dynamics Among A Management Team? 10/2/2023

    See the answer from David Pyott, chairman at London Business School, a board member at Alnylam Therapeutics, and the former chairman and CEO of Allergan.

  10. Rescuing A Company's Core Purpose 10/2/2023

    When Dr. Scott Braunstein moved from his position as chairman of the board and interim CEO to become permanent CEO of Marinus Pharmaceuticals in August 2019, he had already concluded an overbroad focus was holding the company back.